
Lexicon Pharmaceuticals Incorporation (NASDAQ:LXRX): Positive Results From Potential Diabetes Drug
Boston, MA 10/02/2013 (wallstreetpr) – Lexicon Pharmaceuticals Incorporation is a biopharmaceutical company that focus on the discovery and development of penetrating treatments of the existent













